November 18, 2026

India’s first indigenous H5N1 bird flu vaccine for chickens to be launched on Nov 20

Bhopal, Nov 18 (TNT) : Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan will dedicate India’s first indigenously developed inactivated H5N1 vaccine for chickens to the nation on November 20 at the ICAR-National Institute of High Security Animal Diseases (NIHSAD) in Bhopal.

The vaccine has been developed by ICAR-NIHSAD against the highly pathogenic avian influenza (HPAI) virus of Clade 2.3.2.1a, commonly known as bird flu, the Institute said on Wednesday.

It is the first indigenous vaccine developed in India to combat this particular strain.

Bird flu is a highly contagious disease affecting poultry and can cause nearly 100 per cent mortality among infected birds, resulting in substantial financial losses to poultry farmers due to culling and trade restrictions.

Since the first detection of the disease in India in 2006, the country has reported more than 500 combined outbreaks of H5N1 and H5N8 subtypes.

The disease poses a major threat to the poultry industry, farmers’ livelihoods and the wider economy.

An uncontrolled outbreak could put more than 20 per cent of India’s poultry population at risk, while its impact could potentially reduce the country’s GDP growth by up to 1.5 per cent.

The 2006 bird flu outbreak caused estimated direct and indirect losses of ₹2,200 crore to ₹3,000 crore.

An outbreak in Manipur also resulted in losses equivalent to 0.5 per cent of the state’s GDP.

The H5N1 Clade 2.3.2.1a strain has been responsible for a majority of bird flu outbreaks in chickens.

In recent years, infections involving this strain have also been detected in mammals and other animal species, besides three reported human cases, raising concerns over its potential transmission across species.

According to the World Health Organisation, 1,003 human cases of H5N1 avian influenza, including 479 deaths, have been reported across 25 countries, including India, since 2003.

The development of the indigenous vaccine assumes significance as no specific commercial vaccine is currently available against the H5N1 virus of Clade 2.3.2.1a.

The vaccine is expected to provide protection against strains of the virus circulating in the country and strengthen India’s preparedness to control bird flu outbreaks, safeguard poultry farmers’ livelihoods and reduce the risk of transmission to other animals and humans.

TNT KS

Share on Social Media

Leave a Reply

Your email address will not be published. Required fields are marked *